SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (234)2/19/2000 1:09:00 PM
From: jeffbas  Read Replies (2) of 438
 
Rick, I would appreciate your opinion on the following since you live with stocks in this industry every day (perhaps somewhat as I live with semiconductor mfg stocks).

Let's assume 2 things on the science - that GZMO goes ahead with an IND this year on aaATIII, and that they go from Phase I/II trials on the melanoma vaccine therapy to the next stage because of positive results (and still have SAGE, p53, breast cancer vaccine initiative, etc). Also assume that either through the Genzyme line of credit or otherwise they raise some needed capital.

With these givens, what market cap range would fit properly into the CURRENT market cap spectrum of whatever somewhat comparable competitors now carry?

Thanks for your help.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News